Cash flow Aimei Health Technology Co., Ltd

Stocks

Delayed Nasdaq Other stock markets 11:19:01 2026-06-11 am EDT			5-day change	1st Jan Change
34.98 ^USD	-7.21%		-13.44%	-45.35%

May. 20	Aimei Health Gets Nasdaq Noncompliance Notice Over Delayed Quarterly Filing	MT
May. 05	Aimei Health Technology Co., Ltd announced that it has received $0.034331 million in funding from Aimei Health Ltd, United Hydrogen Group Inc.	CI

587a67f5cd8e819c35f0912d7d8.mq9moQvtn6197_WS9FS5VYDORaWWHX4CT3stDeNTZbQ.2JYTxEy8-sov3rSqvSfzBsK8IfOgLzdKAkwbfIEnI4Dy5QOSX67r7jijxQ

Published financial data: AIMEI HEALTH TECHNOLOGY CO., LTD

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2023	2024	2025
Selling General & Admin Expenses, Total	42.69K	1.06M	836K
Other Operating Expenses, Total	42.69K	1.06M	836K
Operating Income	-42.69K	-1.06M	-836K
Interest And Investment Income	300K	3.62M	1.9M
Net Interest Expenses	300K	3.62M	1.9M
EBT, Excl. Unusual Items	257K	2.55M	1.06M
EBT, Incl. Unusual Items	257K	2.55M	1.06M
Earnings From Continuing Operations	257K	2.55M	1.06M
Net Income to Company	257K	2.55M	1.06M
Net Income - (IS)	257K	2.55M	1.06M
Net Income to Common Incl Extra Items	257K	2.55M	1.06M
Net Income to Common Excl. Extra Items	257K	2.55M	1.06M
Per Share Items
Net EPS - Basic	0.12	0.28	0.17
Basic EPS - Continuing Operations	0.12	0.28	0.17
Basic Weighted Average Shares Outstanding	2.23M	9.03M	6.17M
Net EPS - Diluted	0.12	0.28	0.17
Diluted EPS - Continuing Operations	0.12	0.28	0.17
Diluted Weighted Average Shares Outstanding	2.23M	9.03M	6.17M
Normalized Basic EPS	0.07	0.18	0.11
Normalized Diluted EPS	0.07	0.18	0.11
Supplemental Items
EBITA	-42.69K	-1.06M	-836K
EBIT	-42.69K	-1.06M	-836K
Normalized Net Income	161K	1.6M	662K
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	836K

Fiscal Period: December	2023	2024	2025
Assets
Cash And Equivalents	581K	28.21K	2.93K
Total Cash And Short Term Investments	581K	28.21K	2.93K
Prepaid Expenses	-	2.18K	-
Total Current Assets	581K	30.38K	2.93K
Other Long-Term Assets, Total	69.89M	73.78M	12.1M
Total Assets	70.47M	73.81M	12.1M
Liabilities
Accrued Expenses, Total	24.84K	300K	448K
Short-term Borrowings	-	228K	2.02M
Other Current Liabilities	-	290K	900K
Total Current Liabilities	24.84K	817K	3.37M
Other Non Current Liabilities	70.58M	74.47M	12.79M
Total Liabilities	70.6M	75.29M	16.16M
Common Stock, Total	213	213	213
Retained Earnings	-134K	-1.48M	-4.06M
Total Common Equity	-134K	-1.48M	-4.06M
Total Equity	-134K	-1.48M	-4.06M
Total Liabilities And Equity	70.47M	73.81M	12.1M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	9.03M	8.03M	3.17M
ECS Total Common Shares Outstanding	9.03M	9.03M	3.17M
Book Value / Share	-0.01	-0.16	-1.28
Tangible Book Value	-134K	-1.48M	-4.06M
Tangible Book Value Per Share	-0.01	-0.16	-1.28
Total Debt	0	228K	2.02M
Net Debt	-581K	199K	2.02M
Account Code - Inventory Valuation	3	3	3
Part Time Employees	2	2	2

Fiscal Period: December	2023	2024	2025
Net Income	257K	2.55M	1.06M
Other Operating Activities, Total	-294K	-3.62M	-1.9M
Change in Other Net Operating Assets	37.26K	392K	271K
Cash from Operations	0	-672K	-565K
Other Investing Activities, Total	-105M	-278K	63.58M
Cash from Investing	-105M	-278K	63.58M
Short Term Debt Issued, Total	207K	397K	2.29M
Total Debt Issued	310K	397K	2.29M
Short Term Debt Repaid, Total	-210K	-	-
Total Debt Repaid	-315K	-	-
Issuance of Common Stock	109M	-	-
Repurchase of Common Stock	-	-	-65.33M
Other Financing Activities, Total	-3.11M	-	-
Cash from Financing	105M	397K	-63.04M
Net Change in Cash	871K	-553K	-25.28K
Supplemental Items
Levered Free Cash Flow	-	-103K	238K
Unlevered Free Cash Flow	-	-103K	238K
Change In Net Working Capital	-	-562K	-760K
Net Debt Issued / Repaid	-5.43K	397K	2.29M

Fiscal Period: December	2023	2024	2025
Profitability
Return on Assets	-	-0.92	-1.22
Return on Total Capital	-	96.24	31.82
Return On Equity %	-	-316.9	-38.29
Return on Common Equity	-	-316.9	-38.29
Short Term Liquidity
Current Ratio	23.38	0.04	0
Quick Ratio	23.38	0.03	0
Operating Cash Flow to Current Liabilities	0	-0.82	-0.17
Long Term Solvency
Total Debt/Equity	-	-15.42	-49.87
Total Debt / Total Capital	-	-18.23	-99.48
Total Liabilities / Total Assets	100.19	102	133.53
Growth Over Prior Year
EBITA, 1 Yr. Growth %	-	2.39K	-21.51
EBIT, 1 Yr. Growth %	-	2.39K	-21.51
Earnings From Cont. Operations, 1 Yr. Growth %	-	892.76	-58.48
Net Income, 1 Yr. Growth %	-	892.76	-58.48
Normalized Net Income, 1 Yr. Growth %	-	892.75	-58.48
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	-39.29
Total Assets, 1 Yr. Growth %	-	4.75	-83.6
Tangible Book Value, 1 Yr. Growth %	-	1K	174.87
Common Equity, 1 Yr. Growth %	-	1K	174.87
Cash From Operations, 1 Yr. Growth %	-	-	-15.94
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-330.72
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-330.72
Compound Annual Growth Rate Over Two Years
EBITA, 2 Yr. CAGR %	-	-	342.47
EBIT, 2 Yr. CAGR %	-	-	342.47
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	103.03
Net Income, 2 Yr. CAGR %	-	-	103.03
Normalized Net Income, 2 Yr. CAGR %	-	-	103.03
Total Assets, 2 Yr. CAGR %	-	-	-58.56
Tangible Book Value, 2 Yr. CAGR %	-	-	450.1
Common Equity, 2 Yr. CAGR %	-	-	450.1